In-vitro and in-vivo models for hepatitis B cure research

Lena Allweiss; Helene Strick-Marchand

doi:10.1097/COH.0000000000000616

Journal articles

In-vitro and in-vivo models for hepatitis B cure research

Lena Allweiss ¹ Helene Strick-Marchand ^{2, *}

* Corresponding author

1 UKE - Universitaetsklinikum Hamburg-Eppendorf = University Medical Center Hamburg-Eppendorf [Hamburg]

2 Immunité Innée - Innate Immunity

Abstract : Antiviral therapy for chronic hepatitis B infection is rarely curative, thus research in HBV cure strategies is a priority. Drug development and testing has been hampered by the lack of robust cell culture systems and small animal models. This review summarizes existing models for HBV cure research and focuses on recent developments since 2017 until today.

Document type :

Journal articles

Domain :

Life Sciences [q-bio] / Microbiology and Parasitology / Virology

Complete list of metadata

https://hal-pasteur.archives-ouvertes.fr/pasteur-02875586
Contributor : Helene Strick-Marchand Connect in order to contact the contributor
Submitted on : Friday, June 19, 2020 - 6:17:46 PM
Last modification on : Wednesday, November 3, 2021 - 9:31:23 AM

In-vitro and in-vivo models for hepatitis B cure research

Identifiers

Collections

Citation

Export

Metrics

In-vitro and in-vivo models for hepatitis B cure research

Identifiers

Collections

Citation

Export

Share

Metrics